Happening Globally

Walmart escapes class action over ‘non-drowsy’ cough syrup claim & More News


  • Preemption, lack of standing doom New York woman’s claims, judge finds
  • Similar lawsuits against other companies are pending

(Reuters) – Walmart Inc has escaped a proposed class action lawsuit accusing it of falsely marketing store-brand cough syrup as “non-drowsy.”

U.S. District Judge Lewis Liman in Manhattan ruled Friday that plaintiff Aileen Goldstein’s claims for economic damages were blocked by federal drug law, and that she had no standing to ask for a court order against Walmart’s marketing because she was not likely to be injured by it in the future.

Lawyers for Goldstein and Walmart did not immediately respond to requests for comment.

Goldstein alleged in her 2022 lawsuit that she became drowsy after taking an Equate-brand cough syrup containing the active ingredient dextromethorphan hydrobromide (DXM), despite the label promising it was non-drowsy. She said DXM, which is also found in the brand-name Robitussin cough syrup, is in fact known to cause drowsiness in some people.

Goldstein, seeking to represent a nationwide class, brought claims under the federal Magnuson-Moss Warranty Act and various state consumer protection laws. She sought money damages, saying she would not have bought the product without the false claim, and an order prohibiting the allegedly misleading marketing.

Walmart, moving to dismiss, argued that claims were preempted by the federal Food, Drug and Cosmetic Act (FDCA), which gives the U.S. Food and Drug Administration authority to regulate drugs. It also said Goldstein had no standing to ask for an injunction because, now that she no longer trusts the “non-drowsy” representation, she will not be harmed by it again.

Liman agreed on both counts. He said that, while the FDA had not explicitly approved the “non-drowsy” representation, it did require drowsiness to be disclosed as a side effect of some drugs, but not of DXM.

The FDCA explicitly preempts many state law claims related to over-the-counter drugs, but makes an exception for product liability claims. However, Liman said that exception did not apply to Goldstein’s claims because they alleged only economic loss, not personal injury.

Liman rejected Goldstein’s argument that she will suffer future harm because she can no longer rely on labels, entitling her to an injunction. Now that she knows she cannot rely on labels, he said, the labels are “immaterial to her future decisions to purchase the product.”

Goldstein’s case is one of a number of similar proposed class actions filed around the country against companies including Walgreens Boots Alliance Inc, Rite Aid Corp and brand-name Robitussin maker GlaxoSmithKline Plc over their marketing of DXM-containing cough syrup as non-drowsy. Some of these claims have been dismissed, but others remain pending.

The case is Goldstein v. Walmart Inc, U.S. District Court for the Southern District of New York, No. 1:22-cv-00088.

For Goldstein: Simon Franzini and Jonas Jacobson of Dovel & Luner

For Walmart: Kevin Underhill and Emily Weissenberger of Shook, Hardy & Bacon

Our Standards: The Thomson Reuters Trust Principles.

Brendan Pierson

Thomson Reuters

Brendan Pierson reports on product liability litigation and on all areas of health care law. He can be reached at [email protected]

Walmart escapes class action over ‘non-drowsy’ cough syrup claim

I have made it my goal to provide all of your most recent news today 2022 with the use of this website, and I think that you are going to like all of this news a great deal since all of the news that we always deliver in this news is always present. It is currently a hot issue, regardless of what the most recent news may have been.

it was always our effort to reach you so that you keep getting the latest news and that you always keep getting the information of news through us for free and also tell you, people. this includes but is not limited to Electricity News, Degree News, Donate News, Bitcoin News, Trading News, Real Estate News, Gaming News, Trending News, Digital Marketing, Telecom News, Beauty News, Banking News, Travel News, Health News, Cryptocurrency News, Claim News. it was always our effort to reach you that you keep getting Please include any additional information that is relevant to the many different forms of news that will be

Walmart escapes class action over ‘non-drowsy’ cough syrup claim

You will enjoy this news that I have compiled and distributed to you very much, and in it, we will continue to bring topics for you people on a regular basis, so that you can continue to obtain news information on topics that are currently popular and it is our objective to be able to provide you with this information.

any and all news without going through us first, allowing us to provide you with the most up-to-date and accurate information without charging you a fee. This will allow you to go further by acquiring the details of the news in conjunction with you. After some time has passed, we shall proceed.

to provide information on today’s world news update types of the latest news through posts on our website so that you always keep moving forward in that news and whatever kind of information will be there, it will definitely be conveyed to you people. This is so that you can always keep moving forward in that news.

Walmart escapes class action over ‘non-drowsy’ cough syrup claim

All of these news items that I have presented to you are or will be the most unique and best news that you people are not going to be able to get anywhere else. In addition, I have made all of this information, including Trending News, Breaking News, Health News, Science News, Sports News, Entertainment News, Technology News, Business News, and World News, available to each and every one of you so that you are always connected with the news, remain ahead of the curve in the situation, and continue to get today’s news Always go in a direction that is two steps ahead.

Read Entire Article🡽

Back to top button